Article Versions Notes

Sandvik ECS, Aasarød KM, Johnsen G, Hoff DAL, Kulseng B, Hyldmo ÅA, Græslie H, Nymo S, Sandvik J, Fossmark R. The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores—An 11.6-Year Follow-Up Study. Journal of Clinical Medicine. 2022; 11(16):4910. https://doi.org/10.3390/jcm11164910

Sandvik, Elfrid Christine Smith, Kristin Matre Aasarød, Gjermund Johnsen, Dag Arne Lihaug Hoff, Bård Kulseng, Åsne Ask Hyldmo, Hallvard Græslie, Siren Nymo, Jorunn Sandvik, and Reidar Fossmark. 2022. "The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores—An 11.6-Year Follow-Up Study" Journal of Clinical Medicine 11, no. 16: 4910. https://doi.org/10.3390/jcm11164910

Sandvik, E. C. S., Aasarød, K. M., Johnsen, G., Hoff, D. A. L., Kulseng, B., Hyldmo, Å. A., Græslie, H., Nymo, S., Sandvik, J., & Fossmark, R. (2022). The Effect of Roux-en-Y Gastric Bypass on Non-Alcoholic Fatty Liver Disease Fibrosis Assessed by FIB-4 and NFS Scores—An 11.6-Year Follow-Up Study. Journal of Clinical Medicine, 11(16), 4910. https://doi.org/10.3390/jcm11164910